UK engineering firm adi Group has launched a new Life Sciences division to support the needs of the pharmaceutical and life sciences industry. Based in Manchester, the division will provide end-to-end project servicing capabilities, focusing on the design, engineering, and project management of sophisticated environments that meet industry regulatory compliance.
The Life Sciences division aims to prioritize perfect project execution while maintaining a deep understanding of the industry. Unlike traditional approaches that prioritize speed and neglect after-care, adi Life Sciences seeks to become a partner for clients rather than just a service provider. The division will utilize cutting-edge digital technology to develop virtual representations of project requirements, allowing for concept changes before implementation. This not only mitigates risk but also fosters a collaborative environment where all parties can assess progress and adjust parameters as needed.
With a strong emphasis on attention to detail and compliance, the new division will provide services from concept and technical design to implementation and compliance with all regulations. The philosophy of adi Group is that no project is too big or complex for the Life Sciences division to undertake.
The division is led by Darren Lewis, the recently appointed managing director and head of adi Life Sciences. With 30 years of experience in Pharma D&B, Lewis aims to be the partner of choice in the life sciences sector by delivering sophisticated solutions aligned with clients’ requirements.
The team at adi Life Sciences has extensive experience and partnerships with pharmaceutical companies, delivering a wide range of projects over the years. The team’s values of passion, innovation, and technical expertise contribute to their ability to provide efficient and effective designs that meet clients’ goals.
The launch of adi Group’s Life Sciences division marks an exciting development for the company and reinforces its commitment to diversifying its services in multiple industries. The addition of this division in Manchester showcases adi Group’s expansion and willingness to serve the growing demands of the pharmaceutical and life sciences sector.
With a focus on delivering quality projects and building strong client relationships, adi Life Sciences aims to establish itself as a trusted partner and a single point of responsibility for clients in the industry. The potential for growth and innovation in the life sciences sector is vast, and adi Group is well-positioned to contribute to its advancement and success.
